Aldeyra Therapeutics

2 followers

‌

Aldeyra Therapeutics develops treatments for aldehyde toxicity-related diseases including Sjögren-Larsson Syndrome (SLS) and noninfectious anterior uveitis.

Industries

Pharmaceutical

Headquarters

Lexington, United States

Employees

11-50

Links

Org chart

Todd C. Brady

CEO & President

Todd C. Brady

Collapse

Christopher Pearson

Vice President, Commercial Development and Strategy

David J. Clark

Chief Medical Officer

David Noskowitz

Vice President, Regulatory Affairs

Lise L. Kjems

Vice President, Clinical Development

Stephen G. Machatha

Senior Vice President, Technical Operations

Nate Hornbach

Sr. Director, Market Access

Annalisa Webb

Assistant Controller

Lisa Chan

Senior Accountant

Teams

Leadership Team

6 members

Clinical and Commercial Development

5 members

Quality and Regulatory

4 members

Finance

2 members

Similar companies

Catalent

17 followers

Apellis Pharmaceuticals

7 followers

Curia Global

4 followers

Vial

5 followers

Thrive Capital

26 followers

aescape

6 followers

StorONE

6 followers

Render

5 followers

Crusoe

4 followers

FlyQuest

1 follower

RedesignGroup

3 followers

Explore companies